Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Algra

Showing results (1-10 of 294) with videos related to

Pageof 30
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|March 13, 2001
A benefit/risk analysis of the prevention of brain ischaemia with anticoagulant drugs: when, how and whom to treat?A Algra
Nederlands Tijdschrift Voor Geneeskunde|June 4, 1994
[Atherosclerosis also caused by local vascular inflammation]A Algra
Nederlands Tijdschrift Voor Geneeskunde|May 14, 1994
[SPIRIT: new life spirit for anticoagulant treatment in the secondary prevention of brain infarcts? A new study. Stroke Prevention in Reversible Ischaemia Trial]A Algra
Journal of Neurology, Neurosurgery, and Psychiatry|April 21, 1999
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone?A Algra, J Van Gijn, A Algra, et al.
Journal of the Neurological Sciences|September 1, 1997
Dipyridamole and acetylsalicylic acid in the secondary prevention of strokeF R Rosendaal, A Algra
Nederlands Tijdschrift Voor Geneeskunde|August 12, 1999
[Roaming through methodology. XV. Smoking grandfathers and other selection biases]J van Gijn, A Algra
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1996
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemiaA Algra, J van Gijn
Cerebrovascular Diseases (Basel, Switzerland)|December 6, 2005
Anticoagulation in ischemic stroke: opportunities in arterial diseaseJ van Gijn, A Algra
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 1999
Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial originA Algra, J van Gijn
Stroke|June 1, 1994
Ticlopidine, trials, and tortureJ van Gijn, A Algra
Pageof 30

Showing results (1-10 of 294) with videos related to

Sort By:
Pageof 30
Cerebrovascular Diseases (Basel, Switzerland)|March 13, 2001
A benefit/risk analysis of the prevention of brain ischaemia with anticoagulant drugs: when, how and whom to treat?A Algra
Nederlands Tijdschrift Voor Geneeskunde|June 4, 1994
[Atherosclerosis also caused by local vascular inflammation]A Algra
Nederlands Tijdschrift Voor Geneeskunde|May 14, 1994
[SPIRIT: new life spirit for anticoagulant treatment in the secondary prevention of brain infarcts? A new study. Stroke Prevention in Reversible Ischaemia Trial]A Algra
Journal of Neurology, Neurosurgery, and Psychiatry|April 21, 1999
Secondary prevention after cerebral ischaemia of presumed arterial origin: is aspirin still the touchstone?A Algra, J Van Gijn, A Algra, et al.
Journal of the Neurological Sciences|September 1, 1997
Dipyridamole and acetylsalicylic acid in the secondary prevention of strokeF R Rosendaal, A Algra
Nederlands Tijdschrift Voor Geneeskunde|August 12, 1999
[Roaming through methodology. XV. Smoking grandfathers and other selection biases]J van Gijn, A Algra
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1996
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemiaA Algra, J van Gijn
Cerebrovascular Diseases (Basel, Switzerland)|December 6, 2005
Anticoagulation in ischemic stroke: opportunities in arterial diseaseJ van Gijn, A Algra
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 1999
Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial originA Algra, J van Gijn
Stroke|June 1, 1994
Ticlopidine, trials, and tortureJ van Gijn, A Algra
Pageof 30